Physician
Halo Medical Group PLLC
Halo Medical Group PLLC was paid $19.42M by Medicaid between Jan 2018 and Dec 2024, across 121 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 13% of everything it billed.
33Billing provider infoHALO MEDICAL GROUP PLLC
DETROIT, MI 48201
DETROIT, MI 48201
33aNPI1811214489assigned 04/22/2010
33bProvider typeInternal Medicine Physician
28Total paid$19.42M
24GClaims293,648
24DCodes billed121
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Michigan
Rank by total paid#5 of 816
Median peer was paid$70K
This provider vs. median276×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39,472 | $2.30M | |
| 2019 | 38,248 | $2.18M | |
| 2020 | 38,720 | $2.29M | |
| 2021 | 46,397 | $3.03M | |
| 2022 | 46,346 | $2.96M | |
| 2023 | 43,849 | $3.40M | |
| 2024incomplete | 40,616 | $3.26M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 52,906 | 48,049 | $2.55M |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 12% | 13,152 | 12,692 | $2.41M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 10% | 19,738 | 19,565 | $2.03M |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 10% | 12,551 | 12,048 | $1.95M |
| 36475 | 5.3% | 1,439 | 1,274 | $1.02M | |
| 93229 | 4.9% | 1,965 | 1,956 | $942K | |
| J2785 | Injection, regadenoson, 0.1 mg | 4.2% | 7,120 | 6,948 | $814K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 3.2% | 10,775 | 3,929 | $629K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 3.2% | 15,119 | 4,749 | $622K |
| 93970 | 3.1% | 6,262 | 6,207 | $607K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.0% | 6,011 | 5,699 | $578K |
| 99223 | Prolong inpt eval add15 m | 2.9% | 5,288 | 4,932 | $560K |
109 more codes
| 93925 | 2.6% | 4,068 | $508K | |
| 93923 | 2.6% | 7,731 | $505K | |
| 99214 | Doctor's office visit, returning patient (more involved) | 2.4% | 6,476 | $473K |
| 93880 | 2.4% | 4,753 | $457K | |
| 99203 | Doctor's office visit, new patient (routine) | 1.5% | 4,709 | $293K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.4% | 11,022 | $269K |
| 93015 | <1% | 5,080 | $191K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 4,638 | $189K |
| 93458 | <1% | 1,115 | $166K | |
| 93000 | <1% | 19,555 | $166K | |
| 93971 | <1% | 2,222 | $148K | |
| 94729 | <1% | 3,944 | $116K | |
| 94727 | <1% | 3,983 | $91K | |
| 99220 | <1% | 963 | $89K | |
| 94010 | <1% | 5,630 | $88K | |
| 99441 | <1% | 2,976 | $62K | |
| 93298 | <1% | 2,842 | $61K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 586 | $56K |
| 93307 | <1% | 2,152 | $54K | |
| 93272 | <1% | 3,515 | $49K | |
| 93454 | <1% | 398 | $46K | |
| 93978 | <1% | 576 | $46K | |
| 93299 | <1% | 572 | $40K | |
| 93975 | <1% | 251 | $36K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 442 | $33K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,354 | $31K |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 2,031 | $30K |
| 99221 | <1% | 527 | $28K | |
| 93228 | <1% | 2,053 | $27K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 5,832 | $27K |
| 93297 | <1% | 1,192 | $24K | |
| 99443 | <1% | 365 | $22K | |
| J1245 | Injection, dipyridamole, per 10 mg | <1% | 3,350 | $21K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 532 | $21K |
| 93295 | <1% | 797 | $18K | |
| 93270 | <1% | 3,470 | $17K | |
| 99490 | Ccm add 20min | <1% | 421 | $14K |
| 93296 | <1% | 1,031 | $14K | |
| 92928 | <1% | 46 | $14K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 109 | $13K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 995 | $12K |
| J0280 | Injection, aminophyllin, up to 250 mg | <1% | 1,699 | $10K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 130 | $10K |
| 93463 | <1% | 166 | $9K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,703 | $8K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 452 | $7K |
| 99091 | <1% | 632 | $7K | |
| 99284 | Emergency room visit (serious) | <1% | 104 | $6K |
| 80053 | Comprehensive metabolic panel | <1% | 925 | $6K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 546 | $6K |
| 99439 | <1% | 202 | $5K | |
| 80061 | Lipid panel | <1% | 924 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 918 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 646 | $4K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 26 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 380 | $4K |
| 99442 | <1% | 241 | $4K | |
| 99457 | <1% | 371 | $4K | |
| 99152 | <1% | 497 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 499 | $3K |
| 99426 | <1% | 64 | $2K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 29 | $2K |
| 95012 | <1% | 219 | $2K | |
| 93290 | <1% | 108 | $2K | |
| 75716 | <1% | 43 | $2K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 27 | $2K |
| 84439 | <1% | 279 | $2K | |
| 99383 | <1% | 14 | $1K | |
| 75710 | <1% | 33 | $1K | |
| 75625 | <1% | 43 | $1K | |
| 99454 | <1% | 135 | $1K | |
| 93016 | <1% | 85 | $1K | |
| 93294 | <1% | 54 | $910.56 | |
| 93308 | <1% | 26 | $862.62 | |
| 82607 | <1% | 150 | $837.82 | |
| 92978 | <1% | 15 | $823.05 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 12 | $805.10 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 326 | $759.81 |
| 93018 | <1% | 87 | $688.36 | |
| 83735 | <1% | 135 | $542.89 | |
| 84153 | <1% | 64 | $519.38 | |
| 99217 | <1% | 12 | $492.12 | |
| 93244 | <1% | 35 | $437.44 | |
| 93248 | <1% | 41 | $421.68 | |
| 82728 | <1% | 60 | $226.92 | |
| 93246 | <1% | 41 | $186.41 | |
| 92588 | <1% | 12 | $177.64 | |
| 93242 | <1% | 21 | $133.03 | |
| 83540 | <1% | 59 | $107.54 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 40 | $103.16 |
| 99458 | <1% | 149 | $84.45 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 25 | $41.32 |
| 94664 | <1% | 103 | $17.70 | |
| 3077F | <1% | 210 | $0.01 | |
| 90716 | 0% | 24 | $0.00 | |
| 3075F | 0% | 66 | $0.00 | |
| 3079F | 0% | 269 | $0.00 | |
| 3074F | 0% | 636 | $0.00 | |
| 90688 | 0% | 59 | $0.00 | |
| 3048F | 0% | 56 | $0.00 | |
| 90686 | 0% | 105 | $0.00 | |
| 3080F | 0% | 40 | $0.00 | |
| 3044F | 0% | 94 | $0.00 | |
| 99153 | Mod sedat endo service >5yrs | 0% | 42 | $0.00 |
| 90698 | 0% | 12 | $0.00 | |
| 3078F | 0% | 628 | $0.00 | |
| 90670 | 0% | 51 | $0.00 | |
| 3050F | 0% | 106 | $0.00 | |
| 90633 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialELDER, MAHIR (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| River Oaks Primary Care PLLC | Dearborn Heights, MI | $2.01M |
| Halo Primary Care PLLC | Detroit, MI | $639K |
| Mahir D Elder MD PC | Detroit, MI | $110K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.